WO2003000859A3 - Recepteurs couples aux proteines g - Google Patents

Recepteurs couples aux proteines g Download PDF

Info

Publication number
WO2003000859A3
WO2003000859A3 PCT/US2002/020036 US0220036W WO03000859A3 WO 2003000859 A3 WO2003000859 A3 WO 2003000859A3 US 0220036 W US0220036 W US 0220036W WO 03000859 A3 WO03000859 A3 WO 03000859A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein coupled
coupled receptors
gcrec
polynucleotides
agonists
Prior art date
Application number
PCT/US2002/020036
Other languages
English (en)
Other versions
WO2003000859A2 (fr
Inventor
Mariah R Baughn
Narinder K Chawla
Original Assignee
Incyte Genomics Inc
Mariah R Baughn
Narinder K Chawla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Mariah R Baughn, Narinder K Chawla filed Critical Incyte Genomics Inc
Priority to CA002450925A priority Critical patent/CA2450925A1/fr
Priority to EP02746660A priority patent/EP1551872A2/fr
Priority to AU2002316366A priority patent/AU2002316366A1/en
Priority to JP2003507246A priority patent/JP2005500037A/ja
Publication of WO2003000859A2 publication Critical patent/WO2003000859A2/fr
Publication of WO2003000859A3 publication Critical patent/WO2003000859A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Dans différents modes de réalisation, l'invention concerne des récepteurs couplés aux protéines G (GCREC) et des polynucléotides qui identifient et codent pour GCREC. L'invention porte également sur des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes ainsi que sur des méthodes de diagnostic, traitement ou prévention de troubles associés à l'expression aberrante de GCREC.
PCT/US2002/020036 2001-06-22 2002-06-20 Recepteurs couples aux proteines g WO2003000859A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002450925A CA2450925A1 (fr) 2001-06-22 2002-06-20 Recepteurs couples aux proteines g
EP02746660A EP1551872A2 (fr) 2001-06-22 2002-06-20 Recepteurs couples aux proteines g
AU2002316366A AU2002316366A1 (en) 2001-06-22 2002-06-20 G-protein coupled receptors
JP2003507246A JP2005500037A (ja) 2001-06-22 2002-06-20 Ｇタンパク質共役受容体

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US30049401P 2001-06-22 2001-06-22
US60/300,494 2001-06-22
US30532601P 2001-07-13 2001-07-13
US60/305,326 2001-07-13
US30816501P 2001-07-27 2001-07-27
US60/308,165 2001-07-27
US31011501P 2001-08-03 2001-08-03
US60/310,115 2001-08-03
US31141301P 2001-08-10 2001-08-10
US60/311,413 2001-08-10
US31467901P 2001-08-24 2001-08-24
US60/314,679 2001-08-24

Publications (2)

Publication Number Publication Date
WO2003000859A2 WO2003000859A2 (fr) 2003-01-03
WO2003000859A3 true WO2003000859A3 (fr) 2004-01-08

Family

ID=27559646

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/020036 WO2003000859A2 (fr) 2001-06-22 2002-06-20 Recepteurs couples aux proteines g

Country Status (5)

Country Link
EP (1) EP1551872A2 (fr)
JP (1) JP2005500037A (fr)
AU (1) AU2002316366A1 (fr)
CA (1) CA2450925A1 (fr)
WO (1) WO2003000859A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
JP6395426B2 (ja) * 2014-04-14 2018-09-26 花王株式会社 アクリル酸ブチル臭抑制剤の探索方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001027158A2 (fr) * 1999-10-08 2001-04-19 Digiscents Sequences de recepteurs olfactifs
US20020132273A1 (en) * 2000-06-22 2002-09-19 Senomyx, Inc. Receptor fingerprinting, sensory perception, and biosensors of chemical sensants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001027158A2 (fr) * 1999-10-08 2001-04-19 Digiscents Sequences de recepteurs olfactifs
US20020132273A1 (en) * 2000-06-22 2002-09-19 Senomyx, Inc. Receptor fingerprinting, sensory perception, and biosensors of chemical sensants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHANG ET AL.: "The olfactory receptor gene superfamily of the mouse", NATURE NEUROSCIENCE, vol. 5, no. 2, February 2002 (2002-02-01), pages 124 - 133, XP002969023 *

Also Published As

Publication number Publication date
WO2003000859A2 (fr) 2003-01-03
JP2005500037A (ja) 2005-01-06
AU2002316366A1 (en) 2003-01-08
EP1551872A2 (fr) 2005-07-13
CA2450925A1 (fr) 2003-01-03

Similar Documents

Publication Publication Date Title
WO2001098351A3 (fr) Recepteurs couples a la proteine g
WO2001042288A3 (fr) Recepteurs couples a la proteine g
WO2001057085A3 (fr) Récepteurs couplés aux protéines g
WO2001087937A3 (fr) Recepteurs couples aux proteines g
WO2003027228A3 (fr) Recepteurs et proteines associees a une membrane
WO2002010387A3 (fr) Récepteurs couplés à la protéine g
WO2001098323A3 (fr) Recepteurs couples a la proteine g
WO2003048305A3 (fr) Recepteurs et proteines associees aux membranes
WO2001098354A3 (fr) Recepteurs
WO2003070902A3 (fr) Recepteurs et proteines associees aux membranes
WO2001072836A3 (fr) Recepteurs couples a une proteine g
WO2001090359A3 (fr) Recepteurs couples par proteine g
WO2002026825A3 (fr) Récepteurs couplés à la protéine g
WO2002094990A3 (fr) Recepteurs et proteines associees aux membranes
WO2001066742A3 (fr) Recepteurs couples a la proteine g
WO2002063004A3 (fr) Recepteurs couples a la proteine g
WO2003062391A3 (fr) Proteines structurelle associees au cytosquelette
WO2003025130A3 (fr) Recepteurs et proteines associees a la membrane
WO2004100774A3 (fr) Recepteurs et proteines associees a une membrane
WO2002057454A3 (fr) Proteines associees a une membrane et a des recepteurs
WO2003023009A3 (fr) Recepteurs couples a la proteine g
WO2002079448A3 (fr) Récepteurs couplés à la protéine g
WO2003000859A3 (fr) Recepteurs couples aux proteines g
WO2002029061A3 (fr) Recepteurs couples aux proteines g
WO2002046230A3 (fr) Récepteurs couplés à la protéine g

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2450925

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003507246

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002746660

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002746660

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002746660

Country of ref document: EP